SEARCH

SEARCH BY CITATION

References

  • 1
    Roberts JM , Hubel CA . The two stage model of preeclampsia: variations on the theme. Placenta 2009;30(Suppl A):S327.
  • 2
    Maynard SE , Min JY , Merchan J , Lim KH , Li J , Mondal S , et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:64958.
  • 3
    Levine RJ , Maynard SE , Qian C , Lim KH , England LJ , Yu KF , et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:67283.
  • 4
    Levine RJ , Lam C , Qian C , Yu KF , Maynard SE , Sachs BP , et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006;355:9921005.
  • 5
    Chauhan SP , Scardo JA , Magann EF , Devoe LD , Hendrix NW , Martin JN Jr . Detection of growth-restricted fetuses in preeclampsia: a case-control study. Obstet Gynecol 1999;93:68791.
  • 6
    Haddad B , Kayem G , Deis S , Sibai BM . Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol 2007;196:e15.
  • 7
    Roberts DJ , Post MD . The placenta in pre-eclampsia and intrauterine growth restriction. J Clin Pathol 2008;61:125460.
  • 8
    Belghiti J , Kayem G , Tsatsaris V , Goffinet F , Sibai BM , Haddad B . Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011;205:e16.
  • 9
    Mirza FG , Strohsnitter WC , Rivera J , Gyamfi-Bannerman C . Intrauterine growth restriction with abnormal umbilical artery Dopplers: a harbinger for preeclampsia? J Matern Fetal Neonatal Med 2012;25:265861.
  • 10
    Xiong X , Demianczuk NN , Buekens P , Saunders LD . Association of preeclampsia with high birth weight for age. Am J Obstet Gynecol 2000;183:14855.
  • 11
    Xiong X , Demianczuk NN , Saunders LD , Wang FL , Fraser WD . Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002;155:2039.
  • 12
    Rasmussen S , Irgens LM . Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003;101:57583.
  • 13
    Irgens LM . Commentary: on the clinical prediction of pre-eclampsia and its enigmatic aetiology. Int J Epidemiol 2007;36:4201.
  • 14
    Roberts JM , Catov JM . Preeclampsia more than 1 disease: or is it? Hypertension 2008;51:98990.
  • 15
    Hoegsberg B , Gruppuso PA , Coustan DR . Hyperinsulinemia in macrosomic infants of nondiabetic mothers. Diabetes Care 1993;16:326.
  • 16
    Yu CK , Teoh TG , Robinson S . Obesity in pregnancy. BJOG 2006;113:111725.
  • 17
    Espinoza J , Uckele JE , Starr RA , Seubert DE , Espinoza AF , Berry SM . Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 2010;203:e18.
  • 18
    Espinoza J . Uteroplacental ischemia in early- and late-onset pre-eclampsia: a role for the fetus? Ultrasound Obstet Gynecol 2012;40:37382.
  • 19
    Irgens LM . The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 2000;79:4359.
  • 20
    World Health Organization. Global Database on Body Mass Index. Geneva: World Health Organization, 2013. [http://apps.who.int/bmi/]. Accessed 9 November 2013.
  • 21
    Gifford RW , August PA , Cunningham G , Green LA , Lindheimer MD , McNellis D , et al. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S122.
  • 22
    Gissler M , Louhiala P , Hemminki E . Nordic Medical Birth Registers in epidemiological research. Eur J Epidemiol 1997;13:16975.
  • 23
    Engeland A , Bjørge T , Daltveit AK , Vollset SE , Furu K . Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009;88:10839.
  • 24
    Thomsen LC , Klungsøyr K , Roten LT , Tappert C , Araya E , Bærheim G , et al. Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2013;92:94350.
  • 25
    Vangen S , Stoltenberg C , Holan S , Moe N , Magnus P , Harris JR , et al. Outcome of pregnancy among immigrant women with diabetes. Diabetes Care 2003;26:32732.
  • 26
    Chen XK , Wen SW , Smith GN , Yang Q , Walker MC . New-onset hypertension in late pregnancy and fetal growth: different associations between singletons and twins. Hypertens Pregnancy 2007;26:25972.
  • 27
    Powe CE , Ecker J , Rana S , Wang A , Ankers E , Ye J , et al. Preeclampsia and the risk of large-for-gestational-age infants. Am J Obstet Gynecol 2011;204:e16.
  • 28
    Brazy JE , Grimm JK , Little VA . Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982;100:26571.
  • 29
    Moore MP , Redman CW . Case–control study of severe pre-eclampsia of early onset. Br Med J (Clin Res Ed) 1983;287:5803.
  • 30
    Egbor M , Ansari T , Morris N , Green CJ , Sibbons PD . Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006;113:5809.
  • 31
    Gilbert JS , Ryan MJ , LaMarca BB , Sedeek M , Murphy SR , Granger JP . Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008;294:H54150.
  • 32
    Gant NF , Hutchinson HT , Siiteri PK , MacDonald PC . Study of the metabolic clearance rate of dehydroisoandrosterone sulfate in pregnancy. Am J Obstet Gynecol 1971;111:55563.
  • 33
    Easterling TR , Benedetti TJ , Schmucker BC , Millard SP . Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990;76:10619.
  • 34
    Zavalza-Gomez AB . Obesity and oxidative stress: a direct link to preeclampsia? Arch Gynecol Obstet 2011;283:41522.
  • 35
    Bodnar LM , Ness RB , Harger GF , Roberts JM . Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005;162:1198206.
  • 36
    Sohlberg S , Stephansson O , Cnattingius S , Wikstrom AK . Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens 2012;25:1205.
  • 37
    Djelantik AA , Kunst AE , van der Wal MF , Smit HA , Vrijkotte TG . Contribution of overweight and obesity to the occurrence of adverse pregnancy outcomes in a multi-ethnic cohort: population attributive fractions for Amsterdam. BJOG 2012;119:28390.
  • 38
    Freeman DJ . Effects of maternal obesity on fetal growth and body composition: implications for programming and future health. Semin Fetal Neonatal Med 2010;15:11318.
  • 39
    Sebire NJ , Jolly M , Harris JP , Wadsworth J , Joffe M , Beard RW , et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord 2001;25:117582.
  • 40
    Schaefer-Graf UM , Heuer R , Kilavuz O , Pandura A , Henrich W , Vetter K . Maternal obesity not maternal glucose values correlates best with high rates of fetal macrosomia in pregnancies complicated by gestational diabetes. J Perinat Med 2002;30:31321.
  • 41
    Schaefer-Graf UM , Graf K , Kulbacka I , Kjos SL , Dudenhausen J , Vetter K , et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008;31:185863.